Clinical Trials · NCT00001849

New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

CompletedPhase 2Octreotide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment
95
Start date
May 1999
Locations
1 site, United States
Primary endpoint
Sensitivity of Imaging Modalities for the Detection of ACTH-secreting Non-pituitary Tumor in Patients
View Octreotide compound reference